Delivery Order SPE2DB22D2218-SPE2DB24FR2WE

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566697371 ! FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a specialized pharmaceutical product. The contract has a firm fixed price of $2,537.60 and a completion date of December 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566945457 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,331.60 and an ultimate completion date of January 16, 2025. It is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fomepizole 1.5 GM/1.5 ML Vial 1.5ML, a medical product, with a ceiling value of $1,701.39 and a period of performance through February 13, 2025. The contract is a firm fixed-price type and was not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4566570419 FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a specialty medication. The $5,075.20 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on November 29, 2024, with a completion date of December 2, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, the corporate office division of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of the drug fomepizole, with a ceiling value of $1,038.64 and a completion date of May 10, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fomepizole 1.5 GM/1.5 ML Vials, a medication used in the treatment of certain types of poisoning. The contract has a firm fixed price of $2,257.27 and a period of performance through June 24, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award (SPE2DB20D3103|SPE2DB22FP2A9) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,531.34 firm fixed-price delivery order is for the pharmaceutical product Fomepizole 1.5 GM/1.5 ML Vial 1.5ML. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,698.90, is for the delivery of 4,567,250 amber vials to support federal government medical programs. The contract is a firm fixed-price delivery order with a completion date of February 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $49,043.14, is for the procurement of various pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, syringes, vials, and other medical commodities. The contract is a Firm Fixed Price (FFP) delivery order, with a period of performance through May 6, 2024. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,630.79, is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment. The contract is a Firm Fixed Price (FFP) delivery order, with a completion date of August 13, 2024. This award is part of...
  • SPE2DB22D2218
    Indefinite Delivery Contract
  • SPE2DB22D2218-SPE2DB24FR2WE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML. The contract has a firm fixed price of $3,640.66 and a completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:05 AM